The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EA2201: An ECOG-ACRIN phase II study of neoadjuvant nivolumab plus ipilimumab and short course radiation in MSI-H/dMMR rectal tumors.
 
Kristen Keon Ciombor
Consulting or Advisory Role - Array BioPharma; Bayer; Foundation Medicine; Lilly; Merck; Natera; Pfizer; Replimune; Research to Practice; Seagen; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Nucana (Inst); Onyx (Inst); Pfizer (Inst); Pfizer/Calithera (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Array BioPharma
 
Sung Chul Hong
No Relationships to Disclose
 
Cathy Eng
Consulting or Advisory Role - Bayer Health; Gilead/Forty Seven; GlaxoSmithKline; Hookipa Biotech; Mirati Therapeutics; natera; Pfizer
Research Funding - Elevar Therapeutics; Hutchison China Meditech; Merck; Pfizer
 
Xin Yao
Honoraria - Research to Practice; Xcenda
 
May Thet Cho
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Basilea; Eisai; Exelixis; Genentech/Roche; Ipsen; QED Therapeutics; Seagen; Taiho Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Daiichi Sankyo/Astra Zeneca; Helsinn Therapeutics; natera; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); incyte (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Y. Nancy You
No Relationships to Disclose
 
Prajnan Das
No Relationships to Disclose
 
Anuradha Bapsi Chakravarthy
No Relationships to Disclose
 
Peter J. O'Dwyer
Consulting or Advisory Role - Genentech
Research Funding - Amgen (Inst); Array BioPharma (Inst); BBI Healthcare (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); GlaxoSmithKline (Inst); H3 Biomedicine (Inst); Lilly/ImClone (Inst); Minneamrita Therapeutics (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Syndax (Inst); Syndax (Inst); Syndax (Inst); Syndax (Inst); syndax (Inst); Taiho Pharmaceutical (Inst)
Expert Testimony - Dai-ichi Sankyo; Lilly